1 / 26

Challenges and Opportunities in the Adoption of CAP Checklists in Electronic Format

This article explores the challenges and opportunities faced by participant laboratories in the adoption of CAP checklists in electronic format. It discusses the perspectives and experiences of different stakeholders, including pathology laboratories, LIS and registry vendors, and state and hospital registries.

nregina
Download Presentation

Challenges and Opportunities in the Adoption of CAP Checklists in Electronic Format

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Challenges and Opportunities in the Adoption of CAP Checklists in Electronic Format Perspectives and Experience of RPP2 Participant Laboratories NAACCR 2009 Conference Lewis A. Hassell, MD

  2. Pathology Laboratories-City of Hope-UPMC-DCPA-NorDx (MMC) State and Hospital RegistriesCA, PA, ME LIS and Registry vendors-Cerner-IMPAC-CNexT Others-CDC NPCR-CAP- SNOMED CT RPP2- Participants

  3. Project endpoint goals • Participant pathology groups report CAP Checklist data in synoptic format for breast, prostate and melanoma • Synoptic electronically encoded data captured from report • Checklist data transmitted electronically to registry and entered into database

  4. Pathology-Specific Project Queries • Will Pathologists use the CAP Checklists as a routine part of reporting? • What barriers exist for registries and laboratories in implementing the CAP Cancer Checklists in electronic format? • What unique opportunities might exist for users of electronic checklists?

  5. Baseline State- Pathology labs • City of Hope– Text only reports • UPMC- Text diagnoses, Synoptic (text) in a separate section of report for many tumor types • DCPA- Text and synoptic (text, locally developed) in diagnosis section of report • NorDx- Text and synoptic (local) in diagnosis section of report

  6. Synoptic Reporting:Implementation Factors • Data element (DE) structure • Data content & maintenance • Synoptic design to facilitate data entry • Workflow integration • Synoptic data in reporting- where? • Monitoring pathologist compliance (!!) • Continuous process and quality improvement From Winters and Parwani, APIII 2007 ADVANCING PRACTICE, INSTRUCTION AND INNOVATION THROUGH INFORMATICS

  7. Pathologist Compliance

  8. Pathologist Compliance • Usage highest in sections or practices with “mandate” • Resistance encountered in complex situations such as multiple tumors, unusual histology, recurrences

  9. Synoptic Reporting Barriers-Pathologist • Data-entry interface and workflow • Traditional view of report ownership • Ignorance of expanded audience • Resistance to externally imposed standards from authoritative organizations– JCAHO, CAP, ASC-CoC and others • Dislike of the rigid, sterile style of synoptic information

  10. Checklist Data Entry Interface— Easy to use? Easy to access? Easy to update? Flexible?

  11. 21st Century View of the Pathology Report • Part of the medical record, often an EMR • Read by many– patient, surgeon, oncologist, coders, insurers, public health personnel • Diagnosis only one part of total picture of disease, stage, and clinical setting • Prescriptive of specific therapy • Must meet quality standards for completeness and consistency • Electronically encoded discrete data?

  12. Barriers to Adoption • Coded database system complexity-Adaptations require adjustments in IT, registry, LIS vendor, workflow • Unevenly distributed costs and benefits between lab, registry, others • Institutional boundaries and control • Rigidity of the status quo

  13. Opportunities • Streamlined workflow • Effort/cost savings • Rules-based quality checks • Data mining • Data sharing with tissue banks, etc. • Compliance

  14. Specimen accessioned Current Workflow- UPMC SynWksh defaults on specimen from part type OR attached to case by gross entry staff [in dev] Resident or Pathologist dictates final diagnosis and synoptic values from SynWksh copy UPMC Pathology Synoptic Worksheet Processing 2007 Transcriptionist attaches SynWksh if not done previously Transcriptionist enters values into on-line SynWksh and marks complete as pertinent, sends case to pathologist Pathologist dictates changes to synoptic values IF Not editing in on-line SynWksh OR AFTER Specimen is amended Pathologist enters values into on-line SynWksh,or edits values if needed Pathologist reviews final diagnosis and default SynWksh text, signs out specimen

  15. Case Accessioned, gross information added, slides to pathologist Pathologist examines slides and enters data into e-checklist; dictates any needed comment Pathologist views report and signs out Smart Checklist extracts items for main diagnosis line and formats report with addition of any dictated information Data immediately transmitted to chart, registry, etc. Potential Future Workflow

  16. OpportunityPotential Time Savings- Registry

  17. Opportunity- Rules application for consistency

  18. Synoptic Reporting: Data Mining Data that can be used for QA, credentialing, research, & teaching

  19. Clerical work flow ACS-CoC ??? LIS vendors and quality, research or teaching concerns Reader preferences Pathology Reporting Basic Cutting Edge Reporting level Level 1 Level 2 Level 3 Level 4 Level 5 Level 6 Description From Srigley et al. J Surg Oncol 2009;99:517-524

  20. Motivators to get closer to Level 6 • Regulatory/Accrediting • Careful workflow planning and implementation of lean, low cost work methods integrated with e-reporting (LIS vendors, etc.) • Catalytic, creative collaboration • Political will (EMR-like incentives) or legislative fiat

  21. Acknowledgements Pathology colleagues at UPMC, COH, MMC and DCPA Anil Parwani, MD Lawrence Weiss, MD Michael Jones, MD Jay Ye, MD Registry Collaborators Molly Schwenn, MD Wendy Aldinger Sharon Winters Castine Verrill Cheryl Moody CDC NPCR Colleagues Ken Gerlach, MPH, CTR Missy Jameson Vendors Cerner IMPAC Other members of the Evaluation Workgroup of RPP2

  22. Outline of presentation • Historical Backdrop of Reporting Pathology Protocols Projects • Specific Pathology-related queries • Accomplishments • Barriers to further implementation • Opportunities or strategies

  23. Traditional Pathologist’s view of the report • Consultation for a patient • Report is addressed to a clinician giving care, or obtaining the sample, or both • Requires style– owned by pathologist • Unique • The “diagnosis” is the critical thing, the rest is secondary

  24. Synoptic Reporting in Pathology-Background • Pathology reports are data-intense • Traditional methods- text only, individual styles numerous • Variability of content, quality and consistency • Significance of individual items sometimes unclear prospectively • Retrospective research required rework

  25. Synoptic Reporting in PathologyBackground • The College of American Pathologist Cancer Protocols and Checklists goal is improving the quality and uniformity of reports. • Many LIS Systems do not support discrete data elements for synoptic data elements thus, the CAP checklists have been incorporated as unstructured text blocks which are embedded in the pathology reports. • Text block data presentation is cumbersome to search and transmit to data repositories

  26. Synoptic Reporting in PathologyBackground • Synoptic reporting schemes attempt to address key quality issues-Consistency-Completeness-Comprehensibility • Efforts of ADASP and CAP led to consensus development of Cancer Protocols  specific site and specimen type Checklists

More Related